Download Files:
NVP-BAW2881
SKU
HY-100394-10 mg
Category Reference compound
Tags Endocrinology; Cancer, Protein Tyrosine Kinase/RTK, Tie;VEGFR
$55 – $704
Products Details
Product Description
– NVP-BAW2881 (BAW2881) is a potent and selective VEGFR2 inhibitor with an IC50 of 4 nM.
Web ID
– HY-100394
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C22H15F3N4O2
References
– [1]Bold G, et al. A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis. J Med Chem. 2016 Jan 14;59(1):132-46.|[2]Halin C, et al. Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. Am J Pathol. 2008 Jul;173(1):265-77.
CAS Number
– 861875-60-7
Molecular Weight
– 424.38
Compound Purity
– 98.17
SMILES
– O=C(C1=C2C=CC(OC3=NC(N)=NC=C3)=CC2=CC=C1)NC4=CC=CC(C(F)(F)F)=C4
Clinical Information
– No Development Reported
Research Area
– Endocrinology; Cancer
Solubility
– DMSO : ≥ 33 mg/mL
Target
– Tie;VEGFR
Isoform
– Tie2;VEGFR1/Flt-1;VEGFR2/KDR/Flk-1;VEGFR3/Flt-4
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.